Screener
Integra LifeSciences IART Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $418.76M+0.8% | $391.92M+2.4% | $434.93M-1.7% | $402.06M+5.6% | $415.61M-0.6% | ||
| $199.02M-3.5% | $174.94M-7.1% | $214.06M+10.6% | $195.07M+8.0% | $206.27M+7.3% | ||
| $219.74M+5.0% | $216.98M+11.6% | $220.87M-11.3% | $206.99M+3.4% | $209.33M-7.3% | ||
| 52.5%+2.1pp | 55.4%+4.6pp | 50.8%-5.5pp | 51.5%-1.1pp | 50.4%-3.7pp | ||
| $24.25M-10.2% | $23.5M-5.0% | $24.79M-20.6% | $22.46M-18.1% | $27M-9.3% | ||
| $172.44M-4.1% | $178.24M-1.8% | $169.27M-5.2% | $169.05M-4.6% | $179.89M-8.0% | ||
| $399.48M-57.0% | $380.45M-4.4% | $411.89M+1.2% | $390.3M+0.3% | $928.28M+120% | ||
| $19.29M+104% | $11.47M+174% | $0-100% | $11.76M+244% | -$512.67M-16,826% | ||
| 4.6%+128pp | 2.9%+7.0pp | 0%-8.0pp | 2.9%+5.1pp | -123.4%-123pp | ||
| $22.99M+9.3% | $22.47M+19.4% | $23.67M+24.7% | $22.73M+17.3% | $21.04M+12.8% | ||
| $4.19M+315% | $4.48M+3,211% | —— | -$842K-140% | -$1.95M-235% | ||
| $4.74M+101% | -$2.41M+92.0% | $0— | -$6.82M+66.5% | -$530.95M-3,397% | ||
| $262K+101% | $2.21M+147% | —— | -$1.42M+85.3% | -$46.88M-1,584% | ||
| $4.48M+101% | -$4.62M+81.7% | -$1.7M— | -$5.4M+49.5% | -$484.07M-3,803% | ||
| 1.1%+118pp | -1.2%+5.4pp | -0.4%— | -1.3%+1.5pp | -116.5%-114pp | ||
| $0.06+101% | -$0.06+81.8% | -$0.02— | -$0.07+50.0% | -$6.31-3,844% | ||
| $61.19M+113% | $53.68M+111% | $42.2M-45.1% | $54.01M+71.1% | -$471.23M-1,358% | ||
| 14.6%+128pp | 13.7%+7.1pp | 9.7%-7.7pp | 13.4%+5.1pp | -113.4%-122pp | ||
| $19.29M+104% | $11.47M+174% | $0-100% | $11.76M+244% | -$512.67M-16,826% |
FAQ
- What is Integra LifeSciences's revenue?
- Integra LifeSciences (IART) generated $1.6B in revenue over the trailing twelve months, up 1.6% year over year.
- Is Integra LifeSciences profitable?
- Integra LifeSciences is not currently profitable: it reported a net loss of $7.2M over the trailing twelve months, a -0.4% net margin.
- What are Integra LifeSciences's profit margins?
- Gross margin is 52.5% and operating margin is 2.6%, with a -0.4% net margin.
- What is Integra LifeSciences's earnings per share?
- Integra LifeSciences's diluted EPS over the trailing twelve months is $-0.09.
- Where does Integra LifeSciences's income statement data come from?
- Every line is extracted from Integra LifeSciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
